Log in to save to my catalogue

Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity

Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7795565

Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity

About this item

Full title

Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity

Publisher

Switzerland: MDPI AG

Journal title

Cancers, 2020-12, Vol.13 (1), p.86

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Immunotherapy is one of the most effective therapeutic options for cancer patients. Five specific classes of immunotherapies, which includes cell-based chimeric antigenic receptor T-cells, checkpoint inhibitors, cancer vaccines, antibody-based targeted therapies, and oncolytic viruses. Immunotherapies can improve survival rates among cancer patient...

Alternative Titles

Full title

Monoclonal Antibody-Based Immunotherapy and Its Role in the Development of Cardiac Toxicity

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7795565

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7795565

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers13010086

How to access this item